Isolated Central Nervous System Relapse in Aggressive Non-Hodgkin's Lymphoma: the Bologna Experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Isolated Central Nervous System Relapse in Aggressive Non-Hodgkin's Lymphoma: the Bologna Experience

Published:1999-01 Issue:5-6 Volume:32 Page:571-576
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Zinzani P. L.,Magagnoli M.,Frezza G.,Prologo G.,Gherlinzoni F.,Bendandi M.,Albertini P.,Babini L.,D'alessandro R.,Tura S.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428199909058415

Reference19 articles.

1. UPDATED KIEL CLASSIFICATION FOR LYMPHOMAS

2. Risk Factors for Central Nervous System Involvement in Non-Hodgkins-Lymphoma a multivariate analysis

3. Risk Factors, Treatment, and Outcome of Central Nervous System Recurrence in Adults With Intermediate-Grade and Immunoblastic Lymphoma

4. Central Nervous System Involvement in Patients with Diffuse Aggressive Non-Hodgkinʼs Lymphoma

5. CENTRAL NERVOUS SYSTEM RELAPSE IN UNFAVOURABLE-HISTOLOGY NON-HODGKIN'S LYMPHOMA: IS PROPHYLAXIS INDICATED?

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions;Cancers;2023-12-21

2. Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients;Blood Advances;2023-01-10

3. CSF and disease;Cerebrospinal Fluid and Subarachnoid Space;2023

4. The Autologous Hematopoietic Stem Cells Transplantation Combination-Based Chimeric Antigen Receptor T-Cell Therapy Improves Outcomes of Relapsed/Refractory Central Nervous System B-Cell Lymphoma;Journal of Oncology;2022-11-29

5. Chimeric antigen receptor engineered T-cell therapy for central nervous system lymphoma;Hematology and Oncology Discovery;2022-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3